Cilian AG

company

About

Cilian AG is a biotechnology company developing and marketing a novel protein expression system based on ciliates.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
€5M
Industries
Biotechnology,Genetics,Life Science
Founded date
Jan 1, 2001
Number Of Employee
1 - 10
Operating Status
Active

Cilian is an emerging biotechnology company developing and marketing a novel expression system. The Company uses a species of Ciliates, a eukaryotic single-cell organism, for the production of enzymes and therapeutic proteins. While Ciliates secrete a number of therapeutically relevant enzymes with high expression rates by nature, recombinant proteins are produced by Ciliates using genetically modified cells.
Leveraging the unique capabilities of the Ciliates, the Company aims to produce proteins at an unmatched quality and price, thereby fulfilling
its mission to improve human health by facilitating access to biopharmaceuticals.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€5M
Cilian AG has raised a total of €5M in funding over 2 rounds. Their latest funding was raised on Apr 2, 2004 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 2, 2004 Series B €5M 1 Limburg Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cilian AG is funded by 1 investors. Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Limburg Ventures Yes Series B